[1]
A. Dinkova-Kostova, “Keap1/Nrf2 as a druggable target”, arhfarm, vol. 72, no. Suppl. 4, p. S147, Oct. 2022, Accessed: Nov. 19, 2026. Available: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/37719